Chun-I Sze

Chun-I Sze


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
SPSubbiah Pugazhenthi
Subbiah Pugazhenthi
MWMaorong Wang
Maorong Wang
SPSerena Pham
Serena Pham
CSChun-I Sze
Chun-I Sze
CEChristopher B Eckman
Christopher B Eckman
Oxidative stress plays an important role in neuronal dysfunction and neuron loss in Alzheimer's brain. Previous studies have reported downregulation of CREB-mediated transcription by oxidative stress and Aβ. The promoter for CREB itself contains cyclic AMP response elements. Therefore, we examined the expression of CREB in the hippocampal neurons of Tg2576 mice, AD post-mortem brain and in cultured rat hippocampal neurons exposed to Aβ aggregates.

15 August 2018 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
CLChan-Chuan Liu
Chan-Chuan Liu
PHPei-Chuan Ho
Pei-Chuan Ho
ILI.-Ting Lee
I.-Ting Lee
YCYu-An Chen
Yu-An Chen
CCChun-Hsien Chu
Chun-Hsien Chu
NCNan-Shan Chang
Nan-Shan Chang
Homozygous null mutation of tumor suppressor WWOX/Wwox gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats. WWOX is frequently downregulated in the hippocampi of patients with Alzheimer’s disease (AD). In vitro analysis revealed that knockdown of WWOX protein in neuroblastoma cells results in aggregation of TRAPPC6AΔ, TIAF1, amyloid β, and Tau in a sequential manner. Indeed, TRAPPC6AΔ and TIAF1, but not tau and amyloid β, aggregates are present in the brains of healthy mid-aged individuals. It is reasonable to assume that very slow activation of a protein aggregation cascade starts sequentially with TRAPPC6AΔ and TIAF1 aggregation at mid-ages, then caspase activation and APP de-phosphorylation and degradation, and final accumulation of amyloid β and Tau aggregates in the brains at greater than 70 years old. WWOX binds Tau-hyperphosphorylating enzymes (e.g., GSK-3β) and blocks their functions, thereby supporting neuronal survival and differentiation. As a neuronal protective hormone, 17β-estradiol (E2) binds WWOX at an NSYK motif in the C-terminal SDR (short-chain alcohol dehydrogenase/reductase) domain. In this review, we discuss how WWOX and E2 block protein aggregation during neurodegeneration, and how a 31-amino-acid zinc finger-like Zfra peptide restores memory loss in mice.

23 December 2010 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MLM-H Lee
M-H Lee
SLS-R Lin
S-R Lin
JCJ-Y Chang
J-Y Chang
LSL Schultz
L Schultz
JHJ Heath
J Heath
NCNan-Shan Chang
Nan-Shan Chang
The role of a small transforming growth factor beta (TGF-β)-induced TIAF1 (TGF-β1-induced antiapoptotic factor) in the pathogenesis of Alzheimer's disease (AD) was investigated. TIAF1 physically interacts with mothers against DPP homolog 4 (Smad4), and blocks SMAD-dependent promoter activation when overexpressed. Accordingly, knockdown of TIAF1 by small interfering RNA resulted in spontaneous accumulation of Smad proteins in the nucleus and activation of the promoter governed by the SMAD complex. TGF-β1 and environmental stress (e.g., alterations in pericellular environment) may induce TIAF1 self-aggregation in a type II TGF-β receptor-independent manner in cells, and Smad4 interrupts the aggregation. Aggregated TIAF1 induces apoptosis in a caspase-dependent manner. By filter retardation assay, TIAF1 aggregates were found in the hippocampi of nondemented humans and AD patients. Total TIAF1-positive samples containing amyloid β (Aβ) aggregates are 17 and 48%, respectively, in the nondemented and AD groups, suggesting that TIAF1 aggregation occurs preceding formation of Aβ. To test this hypothesis, in vitro analysis showed that TGF-β-regulated TIAF1 aggregation leads to dephosphorylation of amyloid precursor protein (APP) at Thr668, followed by degradation and generation of APP intracellular domain (AICD), Aβ and amyloid fibrils. Polymerized TIAF1 physically interacts with amyloid fibrils, which would favorably support plaque formation in vivo.

19 February 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
JCJean-Yun Chang
Jean-Yun Chang
MLMing-Hui Lee
Ming-Hui Lee
SLSing-Ru Lin
Sing-Ru Lin
LYLi-Yi Yang
Li-Yi Yang
HSHsiao-Fang Sun
Hsiao-Fang Sun
NCNan-Shan Chang
Nan-Shan Chang
Trafficking protein particle complex 6A delta (TRAPPC6AΔ) is an extracellular plaque-forming protein in the brain Trafficking protein particle complex 6A delta (TRAPPC6AΔ) is an extracellular plaque-forming protein in the brain

10 December 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
HCHsin-Tzu Chang
Hsin-Tzu Chang
CLChan-Chuan Liu
Chan-Chuan Liu
SCShur-Tzu Chen
Shur-Tzu Chen
YYYe Vone Yap
Ye Vone Yap
NCNan-Shan Chang
Nan-Shan Chang
CSChun-I Sze
Chun-I Sze
The human and mouse WWOX/Wwox gene encodes a candidate tumor suppressor WW domain-containing oxidoreductase protein. This gene is located on a common fragile site FRA16D. WWOX participates in a variety of cellular events and acts as a transducer in the many signal pathways, including TNF, chemotherapeutic drugs, UV irradiation, Wnt, TGF-β, C1q, Hyal-2, sex steroid hormones, and others. While transiently overexpressed WWOX restricts relocation of transcription factors to the nucleus for suppressing cancer survival, physiological relevance of this regard in vivo has not been confirmed. Unlike many tumor suppressor genes, mutation of WWOX is rare, raising a question whether WWOX is a driver for cancer initiation. WWOX/Wwox was initially shown to play a crucial role in neural development and in the pathogenesis of Alzheimer’s disease and neuronal injury. Later on, WWOX/Wwox was shown to participate in the development of epilepsy, mental retardation, and brain developmental defects in mice, rats and humans. Up to date, most of the research and review articles have focused on the involvement of WWOX in cancer. Here, we review the role of WWOX in neural injury and neurological diseases, and provide perspectives for the WWOX-regulated neurodegeneration.

6 March 2017 in Alzheimer's & Dementia: Translational Research & Clinical Interventions
Verified
Journal Article
Open access
MLMing‐Hui Lee
Ming‐Hui Lee
YSYao Hsiang Shih
Yao Hsiang Shih
SLSing‐Ru Lin
Sing‐Ru Lin
JCJean‐Yun Chang
Jean‐Yun Chang
YLYu‐Hao Lin
Yu‐Hao Lin
NCNan-Shan Chang
Nan-Shan Chang
Introduction: Zinc finger‐like protein that regulates apoptosis (Zfra) is a naturally occurring 31‐amino‐acid protein. Synthetic peptides Zfra1–31 and Zfra4–10 are known to effectively block the growth of many types of cancer cells. Methods: Ten‐month‐old triple‐transgenic (3×Tg) mice for Alzheimer's disease (AD) received synthetic Zfra peptides via tail vein injections, followed by examining restoration of memory deficits. Results: Zfra significantly downregulated TRAPPC6AΔ, SH3GLB2, tau, and amyloid β (Αβ) aggregates in the brains of 3×Tg mice and effectively restored their memory capabilities. Zfra inhibited melanoma‐induced neuronal death in the hippocampus and plaque formation in the cortex. Mechanistically, Zfra blocked the aggregation of amyloid β 42 and many serine‐containing peptides in vitro, suppressed tumor necrosis factor–mediated NF‐κB activation, and bound cytosolic proteins for accelerating their degradation in ubiquitin/proteasome‐independent manner. Discussion: Zfra peptides exhibit a strong efficacy in blocking tau aggregation and amyloid Αβ formation and restore memory deficits in 3×Tg mice, suggesting its potential for treatment of AD.